Edition:
India

Audentes Therapeutics Inc (BOLD.OQ)

BOLD.OQ on NASDAQ Stock Exchange Global Market

27.57USD
17 Nov 2017
Change (% chg)

$0.18 (+0.66%)
Prev Close
$27.39
Open
$27.30
Day's High
$27.74
Day's Low
$26.45
Volume
59,036
Avg. Vol
56,513
52-wk High
$33.26
52-wk Low
$14.00

Latest Key Developments (Source: Significant Developments)

Audentes Therapeutics Q3 ‍loss per share $ 0.88​
Wednesday, 15 Nov 2017 

Nov 14 (Reuters) - Audentes Therapeutics Inc :Audentes Therapeutics reports third quarter 2017 financial results and provides corporate update.Audentes Therapeutics inc qtrly ‍loss per share $ 0.88​.  Full Article

Audentes Therapeutics Q2 net loss $6.43
Thursday, 1 Sep 2016 

Audentes Therapeutics Inc : Audentes Therapeutics Inc Q2 net loss per share, basic and diluted $6.43 . "Plan to file investigational new drug applications for three of our development programs by Q1 of 2017" ."Expect to report preliminary data from all three programs in second half of 2017".  Full Article

Deerfield Management Company, L.P reports 6.68 pct stake in Audentes Therapeutics
Monday, 25 Jul 2016 

: Deerfield Management Company, L.P reports 6.68 pct stake in Audentes Therapeutics as of July 25, 2016 - SEC Filing Source - http://bit.ly/29VbnXH Further company coverage: [BOLD.O] (Bengaluru Newsroom; +1 646 223 8780).  Full Article

Audentes Therapeutics shares open about 27 pct above IPO price in debut
Wednesday, 20 Jul 2016 

: Audentes Therapeutics Inc shares open at $19.00, above IPO price of $15.00 Further company coverage: [BOLD.O] ((Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223 8780;)).  Full Article

Audentes Therapeutics announces initial public offering of 5 mln common shares
Wednesday, 20 Jul 2016 

Audentes Therapeutics Inc : Says initial public offering of 5 million common shares priced at $15 per share . Audentes therapeutics announces pricing of initial public offering .Says shares are expected to begin trading on nasdaq global market on July 20, 2016 under symbol "bold".  Full Article

Audentes Therapeutics sees IPO of 5 mln shares priced between $14-$16 per share
Monday, 11 Jul 2016 

Audentes Therapeutics Inc :Audentes Therapeutics sees IPO of 5 million shares priced between $14 and $16 per share.  Full Article

BRIEF-Audentes Therapeutics Q3 ‍loss per share $ 0.88​

* Audentes Therapeutics reports third quarter 2017 financial results and provides corporate update